Filing Details
- Accession Number:
- 0001209191-20-057768
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-11-10 19:07:11
- Reporting Period:
- 2020-11-06
- Accepted Time:
- 2020-11-10 19:07:11
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1755237 | Cyclerion Therapeutics Inc. | CYCN | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1723846 | William Huyett | C/O Cyclerion Therapeutics, Inc. 301 Binney Street Cambridge MA 02142 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2020-11-06 | 3,827 | $2.52 | 67,590 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with the vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on April 1, 2019.